NICE says that donanemab and lecanemab, the first disease-modifying treatments for early Alzheimer’s disease,  should not be provided on the NHS. 

Chris Lay, CEO of Marsh McLennan UK, is Insurance United Against Dementia's new Campaign Chair.

Today, Wednesday 11th June 2025, the Government delivered their Spending Review, providing insight into the UK Government's plans for spending and investment until 2029-30. 

The Alzheimer’s Society Forget Me Not Appeal will end the devastation caused by dementia. In support of this aim, our celebrity ambassadors have been wearing their pins proudly in this powerful and intimate photo series.

England legend met local attendees affected by dementia at the new Wembley Stadium Memory Café, set up as part of the partnership between Alzheimer's Society and The Football Association (FA).

As one in three people living with dementia in the UK remain undiagnosed, we highlight the six key symptoms to look out for.